PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PYPD PolyPid Ltd.

Trading 06-03 15:11:19 EDT

4.72

-0.15

-3.08%

High4.85	Low4.62	Vol184.05K
Open4.85	D1 Closing4.87	Amplitude4.72%
Mkt Cap90.07M	Tradable Cap48.36M	Total Shares19.08M
T/O871.96K	T/O Rate1.80%	Tradable Shares10.25M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PYPD","market":"US","secType":"STK","nameCN":"PolyPid Ltd.","latestPrice":4.72,"timestamp":1780513609410,"preClose":4.87,"halted":0,"volume":184050,"delay":0,"changeRate":-0.03080082135523621,"floatShares":10245500,"shares":19083200,"eps":-1.77985,"marketStatus":"Trading","change":-0.15,"latestTime":"06-03 15:11:19 EDT","open":4.85,"high":4.85,"low":4.62,"amount":871958.85057,"amplitude":0.047228,"askPrice":4.78,"askSize":295,"bidPrice":4.73,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.77985,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1780516800000},"marketStatusCode":2,"adr":0,"listingDate":1593144000000,"exchange":"NASDAQ","adjPreClose":4.87,"preHourTrading":{"tag":"盘前","latestPrice":4.7638,"preClose":4.87,"latestTime":"09:01 EDT","volume":1030,"amount":4906.69031,"timestamp":1780491665876,"change":-0.1062,"changeRate":-0.021807,"amplitude":0.001273},"postHourTrading":{"tag":"盘后","latestPrice":4.87,"preClose":4.87,"latestTime":"19:51 EDT","volume":14,"amount":67.73,"timestamp":1780444308794,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.026395,"impliedVol":4.0221,"impliedVolPercentile":0.9457},"requestUrl":"/m/hq/s/PYPD/tweets","defaultTab":"tweets","newsList":[{"id":"2640951288","title":"PolyPid submits D-PLEX100 NDA to FDA under rolling review","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951288","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951288?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:32","pubTimestamp":1780317154,"startTime":"0","endTime":"0","summary":"PolyPid completed a rolling NDA submission to the FDA for D-PLEX100 to prevent surgical site infections in colorectal surgery.FDA action date is targeted for Q1 2027 under the PDUFA timeline.Application is backed by Phase 3 SHIELD II data showing a 60% relative risk reduction in infections versus standard care .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL6k1mD8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4585","LU0314104364.USD","NDAQ","IE00BKPKM429.USD","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4112","IE00BN0W2V16.EUR","LU2210149790.SGD","BK4588","PYPD","SG9999014021.USD","BK4007","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640511719","title":"PolyPid - FDA Decision on D-Plex100 Expected in Q1 2027 Under Pdufa Timeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2640511719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640511719?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:30","pubTimestamp":1780317001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUA8LVF4V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640095197","title":"PolyPid Completes New Drug Application Submission to FDA for D-Plex₁₀₀","url":"https://stock-news.laohu8.com/highlight/detail?id=2640095197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640095197?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:30","pubTimestamp":1780317001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUA8LVF4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636184216","title":"PolyPid management attends Craig-Hallum institutional investor conference investor meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2636184216","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636184216?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:32","pubTimestamp":1779280337,"startTime":"0","endTime":"0","summary":"PolyPid management to hold investor meetings at the Craig-Hallum 23rd Annual Institutional Investor Conference on May 28, 2026, in Minneapolis.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDLDZfKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","NDAQ","IE00BN0W2W23.USD","BK4112","IE00B3QW5Z07.USD","BK4588","PYPD","LU2210150020.SGD","SG9999014021.USD","IE00BGHQF748.EUR","BK4585","SG9999014039.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014005.SGD","LU0314104364.USD","IE00BKPKM429.USD","SG9999014013.SGD","BK4007","LU2095319765.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636424028","title":"PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2636424028","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636424028?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:30","pubTimestamp":1779280200,"startTime":"0","endTime":"0","summary":"PETACH TIKVA, Israel, May  20, 2026  (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by el","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/20/3298464/0/en/PolyPid-to-Participate-in-the-Craig-Hallum-23rd-Annual-Institutional-Investor-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["X","BK4585","BK4007","BK4520","BK4006","BK4516","PYPD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636181489","title":"PolyPid’s Earnings Call Signals Tightrope to Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2636181489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636181489?lang=en_us&edition=fundamental","pubTime":"2026-05-20 15:59","pubTimestamp":1779263985,"startTime":"0","endTime":"0","summary":"PolyPid Ltd. (($PYPD)) has held its Q1 earnings call. Read on for the main highlights of the call. PolyPid’s latest earnings call struck a cautious...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypids-earnings-call-signals-tightrope-to-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypids-earnings-call-signals-tightrope-to-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635561734","title":"PolyPid reports Q1 EPS (35c), consensus (43c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635561734","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635561734?lang=en_us&edition=fundamental","pubTime":"2026-05-14 01:09","pubTimestamp":1778692181,"startTime":"0","endTime":"0","summary":"“The first quarter of 2026 marked an important transition for PolyPid (PYPD), as we moved from late-stage development to the final stage prior to d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polypid-reports-q1-eps-35c-consensus-43c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polypid-reports-q1-eps-35c-consensus-43c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635780415","title":"PolyPid Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635780415","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635780415?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:31","pubTimestamp":1778679110,"startTime":"0","endTime":"0","summary":"PolyPid Ltd reports results for the quarter ended December 31 - Earnings SummaryPolyPid Ltd PYPD.OQ reported a quarterly adjusted loss of 35 cents per share for the quarter ended December 31, higher t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL8N41Q1TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635784585","title":"PolyPid Advances D-PLEX₁₀₀ Toward FDA Review as Q1 2026 Loss Narrows and Debt Is Retired","url":"https://stock-news.laohu8.com/highlight/detail?id=2635784585","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635784585?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:58","pubTimestamp":1778673501,"startTime":"0","endTime":"0","summary":"PolyPid ( ($PYPD) ) has provided an update. On May 13, 2026, PolyPid reported first-quarter 2026 results and a major regulatory milestone, having i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypid-advances-d-plex₁₀₀-toward-fda-review-as-q1-2026-loss-narrows-and-debt-is-retired?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypid-advances-d-plex₁₀₀-toward-fda-review-as-q1-2026-loss-narrows-and-debt-is-retired?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4588","PYPD","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635789703","title":"PolyPid Q1 FY26 net loss narrows 7.61% to $7.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635789703","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635789703?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:31","pubTimestamp":1778671881,"startTime":"0","endTime":"0","summary":"PolyPid posted a net loss of USD 7.7 million for the three months ended March 31, 2026, narrowing from USD 8.3 million a year earlier; loss per share improved to USD 0.35 from USD 0.70.R&D expense edged down to USD 5.8 million from USD 6.1 million, while general and administrative costs rose to USD 1.6 million from USD 1.2 million.Cash, cash equivalents, and short-term deposits fell to USD 10.9 million at March 31 from USD 12.9 million at Dec. 31, with operations funded into the second half of 2026.Rolling NDA submission to FDA for D-PLEX100 began March 30, with completion expected imminently; FDA granted a small business waiver of about USD 4.3 million in PDUFA fees.U.S. commercial partnership talks for D-PLEX100 moved into late stages, with an EU filing targeted for the third quarter of 2026 and a PDUFA action date expected in the first quarter of 2027 after NDA acceptance.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDLbjSjmD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4007","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","LU0314104364.USD","BK4112","NDAQ","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","BK4585","IE00BKPKM429.USD","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","PYPD","BK4588","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635781789","title":"PolyPid Q1 EPS $(0.35) Beats $(0.43) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635781789","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635781789?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:31","pubTimestamp":1778671876,"startTime":"0","endTime":"0","summary":"PolyPid Q1 EPS $(0.35) Beats $(0.43) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/PYPD","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635741789","title":"PolyPid Ltd - U.S. Commercial Partnership Discussions for D-Plex100 in Late Stages","url":"https://stock-news.laohu8.com/highlight/detail?id=2635741789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635741789?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:30","pubTimestamp":1778671801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA85XHV8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635789208","title":"Press Release: PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635789208","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635789208?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:30","pubTimestamp":1778671800,"startTime":"0","endTime":"0","summary":"Initiated NDA Submission to the FDA for D-PLEX ; Completion Expected Imminently. PETACH TIKVA, Israel, May 13, 2026  -- PolyPid Ltd.  , an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today provided a corporate update and reported financial results for the three months ended March 31, 2026.-- Initiated NDA Submission to the FDA under Rolling Review:. -- On March 30, 2026, the Company initiated a New Drug Application.  submission to the U.S. Food and Drug Administration.  for D-PLEX , the Company's lead product candidate for the. undergoing colorectal surgery. The first modules, including the. sections, were submitted as part of the rolling review, with. additional components, including the clinical section, expected to. be submitted imminently, marking the completion of the NDA. the Prescription Drug User Fee Act  fee of approximately. the Company to focus its resources on commercialization. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["X","BK4007","BK4585","PYPD","BK4588","BK4006","BK4516","BK4520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635000172","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2635000172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635000172?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:00","pubTimestamp":1778666400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Copa Hldgs A                                     1Q      4.14    4:30 PM. ·FLEX LNG Ltd                                    1Q       .36    1:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSCO","ATAT","CLBT","AUTL","DERM","AKA","CAAP","CBUS","GOOS","BHST","CING","CSWC","ACOG","BGSI","AYTU","BEEM","BTBT","ARX","CLNN","ALT","ALLO","PYPD","BIRK","CELC","CCCC","ABEO","BOOT","BLSH","CNTB","BWAY","BZAI","KARO","ATYR","BN","BTDR","CMPS","AMAT","CPA","ATS","BABA","BBWI","AEBI","CLPT","AVAH","BEAT","PHVS","BTGO","CSIQ","AQST","CCAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634282457","title":"PolyPid Ltd  expected to post a loss of 43 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634282457","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634282457?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:37","pubTimestamp":1778506627,"startTime":"0","endTime":"0","summary":"PolyPid Ltd  expected to post a loss of43cents a share - Earnings Preview PolyPid Ltd PYPD.OQ PYPD.O is expected to  show no change in quarterly revenue when it reports  results on May 13 for the peri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O1GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633691133","title":"PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633691133","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633691133?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:00","pubTimestamp":1778068800,"startTime":"0","endTime":"0","summary":"PETACH TIKVA, Israel, May  06, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (\"PolyPid\" or the \"Company\"), an innovative biopharmaceutical company dedicated to improving patient outcomes by ele","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288762/0/en/PolyPid-to-Report-First-Quarter-2026-Financial-Results-and-Operational-Highlights-on-May-13-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["X","BK4006","BK4585","BK4520","BK4516","BK4588","PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630044713","title":"PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630044713","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630044713?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:30","pubTimestamp":1777379400,"startTime":"0","endTime":"0","summary":"Analysis demonstrates statistically significant reduction in the severity of surgical wound infections, with potential to lower hospital resource utilization following abdominal colorectal surgery PET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/28/3282664/0/en/PolyPid-to-Present-Data-from-SHIELD-II-Phase-3-Trial-Demonstrating-Reduced-Severity-of-Surgical-Site-Infection-at-Surgical-Infection-Society-2026-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627928422","title":"Roth MKM Remains a Buy on PolyPid (PYPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627928422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627928422?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:16","pubTimestamp":1776201395,"startTime":"0","endTime":"0","summary":"In a report released today, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on PolyPid, with a price target of $9.00. Pachaiyappan cove...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627102455","title":"PolyPid says SHIELD II data show D-PLEX100 doxycycline release lasts up to 32 days","url":"https://stock-news.laohu8.com/highlight/detail?id=2627102455","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627102455?lang=en_us&edition=fundamental","pubTime":"2026-04-13 21:15","pubTimestamp":1776086151,"startTime":"0","endTime":"0","summary":"PolyPid scheduled new Phase 3 SHIELD II pharmacokinetic data for D-PLEX100 presentation at ESCMID Global 2026 in Munich on April 19.Analysis supports sustained local antibiotic delivery at surgical incision site with limited systemic exposure, reinforcing intended product profile for post-surgical infection prevention.Update adds clinical support for D-PLEX100 differentiation versus standard systemic prophylaxis during period when infections most often emerge.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL9kWbRd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4588","NDAQ","IE00B64PRP62.GBP","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014039.USD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","PYPD","SG9999014005.SGD","LU2210149790.SGD","BK4585","BK4112","BK4007","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625928098","title":"PolyPid starts trading on Frankfurt Stock Exchange under 2PV, adding to Nasdaq listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2625928098","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625928098?lang=en_us&edition=fundamental","pubTime":"2026-04-08 23:45","pubTimestamp":1775663158,"startTime":"0","endTime":"0","summary":"PolyPid began trading on Frankfurt Stock Exchange under ticker 2PV, expanding access to European investors.Company remains listed on Nasdaq under ticker PYPD.Secondary listing comes as PolyPid starts rolling NDA submission for D-PLEX100 with FDA.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLb56qft:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polypid.com","stockEarnings":[{"period":"1week","weight":0.0062},{"period":"1month","weight":0.0968},{"period":"3month","weight":0.1459},{"period":"6month","weight":0.236},{"period":"1year","weight":0.6508},{"period":"ytd","weight":0.1221}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.054},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.1098},{"period":"1year","weight":0.2815},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.080091},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.020861},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.068892},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.012937},{"month":5,"riseRate":0.5,"avgChangeRate":0.007427},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.000073},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.076054},{"month":8,"riseRate":0.333333,"avgChangeRate":0.004327},{"month":9,"riseRate":0,"avgChangeRate":-0.267226},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.05946},{"month":11,"riseRate":0.666667,"avgChangeRate":0.027739},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.103805}],"exchange":"NASDAQ","name":"PolyPid Ltd.","nameEN":"PolyPid Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PolyPid Ltd.,PYPD,PolyPid Ltd.股票,PolyPid Ltd.股票老虎,PolyPid Ltd.股票老虎国际,PolyPid Ltd.行情,PolyPid Ltd.股票行情,PolyPid Ltd.股价,PolyPid Ltd.股市,PolyPid Ltd.股票价格,PolyPid Ltd.股票交易,PolyPid Ltd.股票购买,PolyPid Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction